$6.920
-0.535 (-7.73%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
PHAT Prediction & Forecast by Similar Chart Analysis
Alphio's PHAT stock price prediction model matches the current Phathom Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.83 (-1.32%). The 1-week path is $6.98 (+0.81%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Phathom Pharmaceuticals Inc Stock?
Phathom Pharmaceuticals (PHAT) is currently trading at $6.92, which is significantly below the average analyst price target of $20. However, the stock has a low RSI of 39.876, indicating it is nearing oversold territory, but it has also experienced a year-to-date decline of 55.95%. The company's recent revenue growth of 88% year-over-year in Q2, reaching $74.3 million, shows potential for recovery. The main risk is the lowered 2026 revenue guidance of $310 million to $325 million, which may impact investor confidence.
PHAT stock price ended at $6.92 on Friday, after losing -7.73%
Phathom Pharmaceuticals Inc (PHAT) last closed at $6.92, losing -7.73%. These facts feed the 1-day and 1-week PHAT price prediction above.
Forecast Drivers
Phathom Pharmaceuticals Inc (PHAT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches PHAT, ranked by similarity.
Seasonality analysis for PHAT
Historically the probability of a positive October return for PHAT is 79.31%. November offers the highest probability of a positive month at 79.49%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for PHAT
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $9.29 | $11.46 | $11.86 | +65.62% |
| Nov 2026 | $6.46 | $8.88 | $10.54 | +28.27% |
| Dec 2026 | $8.43 | $9.73 | $11.97 | +40.56% |
In 2026, Phathom Pharmaceuticals Inc (PHAT) is projected to range from $6.46 to $11.97.
Phathom Pharmaceuticals Inc 2026 monthly forecast
In Oct 2026, Phathom Pharmaceuticals Inc is projected to average $11.46, with a low of $9.29 and high of $11.86.
In Nov 2026, Phathom Pharmaceuticals Inc is projected to average $8.88, with a low of $6.46 and high of $10.54.
In Dec 2026, Phathom Pharmaceuticals Inc is projected to average $9.73, with a low of $8.43 and high of $11.97.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.